<DOC>
	<DOC>NCT00764049</DOC>
	<brief_summary>The aim of this study is to determine whether a simplified device of albumin dialysis also has beneficial effects.</brief_summary>
	<brief_title>Single Pass Albumin Dialysis in Patients With Cirrhosis</brief_title>
	<detailed_description>Albumin dialysis has beneficial effects in patients with acute on chronic liver failure. However, current devices are complex and costly. The aim of this study is to determine whether a simplified device of albumin dialysis also has beneficial effects.</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
	<mesh_term>Hepatorenal Syndrome</mesh_term>
	<mesh_term>Liver Failure, Acute</mesh_term>
	<criteria>Minimum age of 18 years Written consent after information of the patient or, in case of inability, by a parent or a close if he is present. Patient having a cirrhosis researched by previous exams (liver biopsy) or, in the absence of previous diagnosis, diagnosed in view of the results of clinical, biological and morphological data, whatever the origin of the cirrhosis (virus of hepatitis B, virus of hepatitis C, extreme consumption of alcohol or other reasons) Participation to an other study in the 4 weeks before Active digestive bleeding, unchecked by the pharmacological treatments and the endoscopic techniques.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Albumin dialysis</keyword>
	<keyword>Artificial liver support</keyword>
	<keyword>Acute on chronic liver failure</keyword>
</DOC>